Ad is loading...
TEQCX
Price
$25.60
Change
-$0.17 (-0.66%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

TEQCX vs VTSNX

Header iconTEQCX vs VTSNX Comparison
Open Charts TEQCX vs VTSNXBanner chart's image
Touchstone Non-US ESG Equity C
Price$25.60
Change-$0.17 (-0.66%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
TEQCX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TEQCX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TEQCX is a Sell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. TEQCX (661M). VTSNX pays higher dividends than TEQCX: VTSNX (3.29) vs TEQCX (0.03). TEQCX was incepted earlier than VTSNX: TEQCX (21 years) vs VTSNX (14 years). TEQCX is a more actively managed with annual turnover of: 110.00 vs. VTSNX (4.00). TEQCX has a lower initial minimum investment than VTSNX: TEQCX (2500) vs VTSNX (5000000). TEQCX annual gain was more profitable for investors over the last year : 16.93 vs. VTSNX (10.92). VTSNX return over 5 years is better than : 15.91 vs. TEQCX (15.11).
TEQCXVTSNXTEQCX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years14 years-
Gain YTD8.0174.535177%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets661M442B0%
Annual Yield % from dividends0.033.291%
Returns for 1 year16.9310.92155%
Returns for 3 years-11.70-5.86200%
Returns for 5 years15.1115.9195%
Returns for 10 years-35.0729.81-118%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals